Kyle Kurpinski
Investments at Tencent
Seattle, Washington
Overview
Work Experience
Executive Director, Investments, Tencent Exploration Team
2022 - Current
● Investing in data-driven deep tech to improve human lives and planetary resiliency ● Focus areas include biotech, digital health, AI, robotics, agriculture, and more ● Notable investments: - Guardant Health (NASDAQ: GH) - Oscar Health (NYSE: OSCR) - Oxford Nanopore (LSE: ONT.L) - Metagenomi (NASDAQ: MGX) - GRAIL (acquired) - Atomwise - Color - Culture Biosciences - Karius - Locus Biosciences
Partner, Tencent Exploration Team
2016 - 2022
Senior Manager, Strategic Initiatives, Tencent Exploration Team
2015 - 2016
Board Observer
2023
Angel Investor
2018
Investments include: Arpeggio Biosciences, Helium Health, Locus Biosciences, and more
Board Observer
2017 - 2020
Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.
Raised $118,686,618.00 from Viking Global Investors, Discovery Innovations, Johnson & Johnson Robotics and Digital Solutions, Tencent and Artis Ventures (AV).
Board Observer (acting)
2018 - 2020
Executive Director, Master of Translational Medicine Program
2011 - 2015
● Built and directed a joint professional Master's program between UC Berkeley and UCSF ● Managed curriculum, projects, finances, recruiting, admissions, and more ● Grew program to ~30 students at steady state with a self-sustaining budget
Senior Product Development Engineer
2008 - 2011
● Led R&D of Class II medical devices for soft-tissue regeneration including peripheral nerves ● Expanded company's IP portfolio with multiple patent filings ● Helped secure early-stage financing including investments and grants
Author
2007 - 2010
Co-author of a humorous science fiction guide book: Kyle Kurpinski and Terry D. Johnson. How to Defeat Your Own Clone: And Other Tips for Surviving the Biotech Revolution. New York: Bantam Dell, 2010.
Graduate Student Researcher (PhD program)
2003 - 2008
● Conducted research spanning stem cells, tissue engineering, micro-/nano-fabrication, and more ● Published articles in PNAS, Nano Letters, Biomaterials, and more
Research Assistant
2002 - 2002
● Discovered mutation site of sex-linked genetic disease without samples from affected patients ● Published findings in the American Journal of Medical Genetics
National Institutes of Health is a biomedical research facility that focuses on biomedical and health-related research.
Raised $5,000,000.00 from National Institute of Allergy and Infectious Diseases.